Postpartum pain trial halted after just 3 women enrolled
NCT ID NCT05972681
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether injecting bupivacaine with epinephrine into a vaginal tear after childbirth could reduce pain once the epidural wears off. Only 3 women participated before the trial was stopped early. Because of the tiny sample, no meaningful results were obtained.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine with epinephrine
- What this could lead to
- If it had worked, this could point toward a way to reduce postpartum pain after vaginal tear repair, potentially lowering opioid use and improving recovery.
- What could go wrong
- The trial was terminated early with only 3 participants, so no reliable conclusions can be drawn. It is unclear if the treatment is effective or safe in this setting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VAGINAL LACERATION DURING DELIVERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.